IRIS
DI TARANTO, MARIA DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.686
NA - Nord America 3.487
EU - Europa 2.595
SA - Sud America 439
Continente sconosciuto - Info sul continente non disponibili 154
AF - Africa 101
OC - Oceania 1
Totale 10.463
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.306
SG - Singapore 1.635
RU - Federazione Russa 1.105
CN - Cina 720
VN - Vietnam 672
IT - Italia 666
BR - Brasile 350
HK - Hong Kong 256
DE - Germania 157
FR - Francia 151
NL - Olanda 132
CA - Canada 106
BD - Bangladesh 97
GB - Regno Unito 75
FI - Finlandia 69
IN - India 60
IE - Irlanda 49
JP - Giappone 47
CI - Costa d'Avorio 41
MX - Messico 40
AR - Argentina 35
SE - Svezia 34
UA - Ucraina 33
KR - Corea 32
ZA - Sudafrica 23
IQ - Iraq 22
PL - Polonia 22
TH - Thailandia 22
AT - Austria 19
PH - Filippine 19
CO - Colombia 15
ES - Italia 14
PK - Pakistan 13
EC - Ecuador 12
ID - Indonesia 11
NP - Nepal 10
RO - Romania 10
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
TW - Taiwan 8
BE - Belgio 7
CH - Svizzera 7
PY - Paraguay 7
TR - Turchia 7
VE - Venezuela 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
LT - Lituania 6
MA - Marocco 6
SA - Arabia Saudita 6
JO - Giordania 5
MY - Malesia 5
PE - Perù 5
AL - Albania 4
LV - Lettonia 4
NI - Nicaragua 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
LB - Libano 3
OM - Oman 3
PS - Palestinian Territory 3
SC - Seychelles 3
TN - Tunisia 3
UY - Uruguay 3
UZ - Uzbekistan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
KZ - Kazakistan 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
Totale 10.289
Salva come PNG Salva come JPEG
Città #
Singapore 831
San Jose 700
Ashburn 309
Moscow 239
Hong Kong 233
Beijing 229
Chandler 223
Ho Chi Minh City 204
Hefei 135
Santa Clara 134
Hanoi 127
Naples 123
Los Angeles 102
Council Bluffs 99
Amsterdam 92
Lauterbourg 80
The Dalles 71
Napoli 67
Millbury 66
New York 59
Milan 49
Boston 48
Boardman 47
São Paulo 44
Buffalo 43
Princeton 41
Tokyo 41
Nanjing 40
Haiphong 35
Rome 35
Ottawa 33
Dallas 32
Des Moines 32
Munich 31
Lawrence 27
Redondo Beach 27
Dong Ket 26
Nuremberg 26
Phoenix 26
Toronto 25
Frankfurt am Main 23
Helsinki 23
Da Nang 22
Orem 22
Seoul 22
Denver 21
Seattle 21
Brooklyn 19
Dublin 18
Montreal 18
Warsaw 18
Mexico City 17
Wilmington 17
Washington 16
Jacksonville 15
Rio de Janeiro 15
Woodbridge 15
Chennai 14
Nanchang 13
San Francisco 13
Stockholm 13
Bangkok 12
Chicago 12
Houston 12
Hải Dương 12
Augusta 11
Bologna 11
Brasília 11
Johannesburg 11
Poplar 11
Shenyang 11
London 10
Redwood City 10
Timisoara 10
Baghdad 9
Falkenstein 9
Norwalk 9
Shanghai 9
Biên Hòa 8
Charlotte 8
Curitiba 8
Düsseldorf 8
Ercolano 8
Manchester 8
Nairobi 8
Portsmouth 8
Turku 8
Brussels 7
Cercola 7
Hebei 7
Ninh Bình 7
Tianjin 7
Atlanta 6
Belo Horizonte 6
City of London 6
Dhaka 6
Florence 6
Medellín 6
Mumbai 6
Palermo 6
Totale 5.541
Salva come PNG Salva come JPEG
Nome #
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 187
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 180
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 176
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 167
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 166
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 161
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 160
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 155
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 152
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 151
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 149
Expression of inflammation-related genes in human atherosclerotic plaques. 147
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 147
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 146
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 144
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 144
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 142
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 141
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 139
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 138
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 137
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 137
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 135
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 135
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 135
Carotid Endarterectomy versus Carotid Artery Stenting with Double-Layer Micromesh Carotid Stent: contemporary results of a single-center retrospective study 135
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 135
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 134
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 134
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 133
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 130
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 130
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 129
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 128
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 127
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 127
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 126
Expression of inflammation-related genes in human atherosclerotic plaque. 126
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 126
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 125
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 124
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 123
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 122
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 122
Targeting Nanostrategies for Imaging of Atherosclerosis 121
Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real Life 120
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 119
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 119
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 118
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 118
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 118
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 117
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 116
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 116
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 116
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 115
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 114
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 113
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 112
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 110
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 109
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 109
Advances in Computational Methods for Genetic Diseases 107
Homozygous Familial Hypercholesterolemia in Campania 106
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases 106
Identification of single nucleotide polymorphisms associated to familial combined hyperlipidemia 104
MANAGEMENT OF SEVEREHYPERCHOLESTEROLEMIA IN A FAMILYBEARING C.974G>A LDL RECEPTORMUTATION 102
Molecular diagnosis of Familial Hypercholesterolemia: the utility of a country specific protocol. 101
IDENTIFICATION OF LDLR MUTATIONSIN PATIENTS WITH FAMILIAL COMBINEDHYPERLIPIDEMIA 98
Identification of deletions in LDRR gene by multiplex ligation-dependent probe amplification analysis 95
IDENTIFICATION AND FUNCTIONALCHARACTERIZATION OF A NEW MUTATIONLEADING TO DEFECTIVE UPTAKEOF LDL-LDLR COMPLEX 94
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review 91
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 89
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 88
The role of galectin-3 and LP(A) in atherosclerosis: A combined analysis of serum levels and plaque characteristics 87
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 86
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9 85
Metalloproteinases between History, Health, Disease, and the Complex Dimension of Social Determinants of Health 84
Valutazione di parametri di ossidazione in placche aterosclerotiche e plasma di pazienti endoarteriectomizzati. 80
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 80
Galectin-3 in cardiovascular diseases 74
Clinical and Pathological Correlations in Chronic Venous Disease 67
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 66
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia 65
Statistical and Computational Methods for Genetic Diseases: An Overview 56
Multiparametric platform for profiling lipid trafficking in human leukocytes 56
Studio del miRNome e caratterizzazione funzionale del LDLR per l’identificazione di nuove cause molecolari dell’ipercolesterolemia familiare [miRNome study and functional characterization of LDLR for the identification of new molecular causes of Familial Hypercholesterolemia] 50
Genetic Assessment and Clinical Correlates in Severe Hypertriglyceridemia: A Systematic Review 26
A delayed diagnosis of familial chylomicronemia syndrome in an elderly patient: Clinical implications of late-onset disease 16
Diagnosis of Familial Hypercholesterolemia in Children: From Clinical Features Through Gene Variants to Polygenic Score 13
Real-world lipid outcomes after switching PCSK9-targeting therapies in heterozygous familial hypercholesterolemia: the SHIFT-FH study. 4
Totale 10.463
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022397 0 0 2 14 14 22 7 17 32 15 116 158
2022/2023573 72 23 24 26 91 70 3 57 87 85 29 6
2023/2024503 30 69 40 35 28 49 12 70 4 20 76 70
2024/20252.583 115 117 22 90 61 157 267 177 162 265 942 208
2025/20265.201 599 338 471 444 902 223 624 235 661 357 186 161
2026/2027559 207 257 95 0 0 0 0 0 0 0 0 0
Totale 10.463